glp 1 and liver Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty disease (NAFLD) non-alcoholic steatohepatitis (NASH) GLP-1 Receptor Agonists as Treatments

Full dose or microdose

They work by mimicking the effects of the naturally occurring hormone called glucagon-like peptide-1 (GLP-1), which is responsible for regulating insulin and blood sugar levels

Insulin for Weight Loss

Eli Lilly makes the best-selling GLP-1 drug, and sales are accelerating.

Key Findings: - Increased risk of going over recommended weight gain limits - Higher chances of preterm birth (from 13% to 17%) - Rising cases of gestational diabetes (15% to 20%) - Nearly half faced high blood pressure issues While baby sizes and C-section rates remained similar, the impact on maternal health is significant

Reddy's Laboratories Limited for manufacturing...